Literature DB >> 12052814

Clinical endpoints in trials of drugs for cancer: time for a rethink?

P P Koopmans1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12052814      PMCID： PMC1123334          DOI： 10.1136/bmj.324.7350.1389

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  18 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Lotronex and the FDA: a fatal erosion of integrity.

Authors:  R Horton
Journal:  Lancet       Date:  2001-05-19       Impact factor: 79.321

3.  The cost effectiveness of combination antiretroviral therapy for HIV disease.

Authors:  K A Freedberg; E Losina; M C Weinstein; A D Paltiel; C J Cohen; G R Seage; D E Craven; H Zhang; A D Kimmel; S J Goldie
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

Review 4.  Risk:benefit analysis of drugs in practice. The doctor, the patient and the licensing authority.

Authors: 
Journal:  Drug Ther Bull       Date:  1995-05

5.  Registration of drugs for treating cancer and HIV infection: a plea to carry out phase 3 trials before admission to the market.

Authors:  P P Koopmans
Journal:  BMJ       Date:  1995-05-20

Review 6.  Patient choice in managing cancer.

Authors: 
Journal:  Drug Ther Bull       Date:  1993-09-27

7.  Measuring patients' views: the optimum outcome measure.

Authors:  J E Ware
Journal:  BMJ       Date:  1993-05-29

Review 8.  Faster evaluation of vital drugs.

Authors:  D A Kessler; K L Feiden
Journal:  Sci Am       Date:  1995-03       Impact factor: 2.142

Review 9.  Adverse effects of antiretroviral therapy.

Authors:  A Carr; D A Cooper
Journal:  Lancet       Date:  2000-10-21       Impact factor: 79.321

Review 10.  Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

Authors:  R Collins; S MacMahon
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321
View more
  1 in total

1.  Review of microdialysis in brain tumors, from concept to application: first annual Carolyn Frye-Halloran symposium.

Authors:  Ramsis K Benjamin; Fred H Hochberg; Elizabeth Fox; Peter M Bungay; William F Elmquist; Clinton F Stewart; James M Gallo; Jerry M Collins; Robert P Pelletier; John F de Groot; Robert C Hickner; Idil Cavus; Stuart A Grossman; O Michael Colvin
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.